Cargando…

Dose-dense adjuvant chemotherapy for primary breast cancer

Adjuvant chemotherapy has been proven to reduce significantly the risk for relapse and death in women with operable breast cancer. Nevertheless, the prognosis for patients presenting with extensive axillary lymph node involvement remains suboptimal. In an attempt to improve on the efficacy of existi...

Descripción completa

Detalles Bibliográficos
Autores principales: Fornier, Monica, Norton, Larry
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1064124/
https://www.ncbi.nlm.nih.gov/pubmed/15743513
http://dx.doi.org/10.1186/bcr1007